Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Change in Inventory (2022 - 2025)

Historic Change in Inventory for InMed Pharmaceuticals (INM) over the last 4 years, with Q4 2025 value amounting to $127091.0.

  • InMed Pharmaceuticals' Change in Inventory rose 20888.82% to $127091.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$85458.0, marking a year-over-year decrease of 12131.52%. This contributed to the annual value of -$283151.0 for FY2025, which is 32759.14% down from last year.
  • According to the latest figures from Q4 2025, InMed Pharmaceuticals' Change in Inventory is $127091.0, which was up 20888.82% from -$70366.0 recorded in Q3 2025.
  • In the past 5 years, InMed Pharmaceuticals' Change in Inventory ranged from a high of $1.1 million in Q2 2022 and a low of -$390329.0 during Q3 2023
  • For the 4-year period, InMed Pharmaceuticals' Change in Inventory averaged around $40239.1, with its median value being -$47308.5 (2024).
  • As far as peak fluctuations go, InMed Pharmaceuticals' Change in Inventory surged by 39908.55% in 2024, and later plummeted by 19015.71% in 2025.
  • InMed Pharmaceuticals' Change in Inventory (Quarter) stood at -$165017.0 in 2022, then crashed by 31.98% to -$217784.0 in 2023, then soared by 46.41% to -$116717.0 in 2024, then skyrocketed by 208.89% to $127091.0 in 2025.
  • Its last three reported values are $127091.0 in Q4 2025, -$70366.0 for Q3 2025, and $147203.0 during Q2 2025.